Lilly investigating allegations of $4.9M in Chinese bribes

Carly Helfand

Eli , the most recent company targeted with bribery accusations in China, is looking into the matter itself. The company says it is "deeply concerned" by that ran Thursday in a private newspaper.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS